Skip to content
ChickenStockChickenStock
Research475830
Orum Therapeutics logo

Orum Therapeutics (475830) stock

KOSDAQ · Pharmaceuticals

KRW 14,760-1.60%(-240)

As of Nov 16, 9:24 AM KST

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

17.31x

P/B

1.72x

P/S

—

Earnings

Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.

Quarters and year-to-date
PeriodRevenueOperating profitNet incomeRevenue YoY
H1 2026Consolidated · Filed Aug 14, 2026KRW 0-KRW 33.4 billionKRW 48.1 billion+244.4%
Q1 2026Consolidated · Filed May 15, 2026—-KRW 18.1 billion-KRW 15.3 billion—
Q4 2025Consolidated · Filed Mar 19, 2026KRW 0-KRW 18.3 billion-KRW 16 billion—
Q3 2025Consolidated · Filed Nov 14, 2025KRW 0-KRW 13.9 billion-KRW 13.6 billion—
Q2 2025Consolidated · Filed Aug 14, 2025KRW 0-KRW 10 billion-KRW 3.8 billion—
Q1 2025Consolidated · Filed May 15, 2025KRW 0-KRW 9.6 billion-KRW 8.6 billion—
Fiscal years
PeriodRevenueOperating profitNet incomeRevenue YoY
FY2025Consolidated · Filed Mar 19, 2026KRW 0-KRW 51.8 billion-KRW 42 billion-99.9%
FY2024Consolidated · Filed Mar 20, 2025KRW 20.9 billion-KRW 8.3 billion-KRW 5.7 billion—
  • Q4 2025 is computed as FY2025 minus 9M 2025.
  • Q3 2025 is computed as 9M 2025 minus H1 2025.
  • Q2 2025 is computed as H1 2025 minus Q1 2025.
  • Year-to-date rows are cumulative from the start of the fiscal year.
Original filing (DART)

Short selling and securities lending

Short sales as a share of trading value, the reported short position and the securities lending balance.

Short-sale share
4.32%
Of trading value on Nov 13, 2026
Short-sale value
KRW 180 million
Previous 20-day average 7.82%
Net short position
255,864 shares
As of Nov 11, 2026 · reported with a two-trading-day lag
Lending balance
2,693,467 shares
As of Nov 13, 2026 · 12.38% of listed shares
Recent short-sale days
DateShareValue
Nov 13, 20264.32%KRW 180 million
Nov 12, 20262.20%KRW 40 million
Nov 11, 20263.11%KRW 70 million
Nov 10, 20265.34%KRW 120 million
Nov 9, 20264.33%KRW 100 million
Nov 6, 20267.40%KRW 230 million
Nov 5, 20269.21%KRW 330 million
Nov 4, 202611.11%KRW 340 million
Nov 3, 202617.19%KRW 480 million
Nov 2, 20269.30%KRW 180 million

The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.

Orum Therapeutics (475830) stock information

KOSDAQ

Orum Therapeutics (475830) is listed on KOSDAQ. Its market capitalization is about KRW 320.4 billion. On trailing-twelve-month earnings the P/E ratio is 17.31, and the P/B ratio is 1.72. Return on equity is 10%. These figures are computed in-house from official filings and are reference information only.

Orum Therapeutics — frequently asked questions

What is the P/E ratio of Orum Therapeutics (475830)?
On a trailing-twelve-month basis, 475830 trades at a P/E ratio of 17.31. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Orum Therapeutics?
475830 has a market capitalization of about KRW 320.4 billion. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.